Can a quick chat in the Doctor's office prevent youth overdoses?

NCT ID NCT07022717

Ongoing Prevention Sponsor: Boston Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 5 times

Summary

This pilot study tests whether a brief overdose prevention education, including naloxone training, is feasible and acceptable for youth ages 13-26 during routine primary care visits. Providers will deliver the intervention to some youth, while others receive usual care. The study aims to see if this approach can be implemented in real-world clinics and whether youth find it helpful.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Brief overdose prevention education and naloxone information
What this could lead to: If successful, this could lead to a scalable, evidence-based overdose prevention program for youth in primary care settings.
What could go wrong: This is a very small pilot study (24 participants) focused on feasibility, not effectiveness. It may not show a reduction in overdose rates or be generalizable beyond this single center.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERDOSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Drug Overdose poisoning

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVERDOSE

Contacts and locations

Locations

Boston Medical Center, Pediatric Primary Care & Family Medicine

Boston, Massachusetts, 02118, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.